Hereditary Neuropathies

ABSTRACT

Hereditary neuropathies represent a clinically diverse group of disorders. Patients can present in a variety of ways-most typically, with slowly progressive distal and symmetric muscle weakness, atrophy, and sensory loss. This article outlines the basic clinical and electrodiagnostic characteristics, pathophysiology, genetics, and diagnostic approach to these conditions.

KEYWORDS

Neuropathy - Charcot-Marie-Tooth disease - hereditary motor and sensory neuropathy - hereditary sensory and autonomic neuropathy - hereditary distal motor neuropathy

REFERENCES

• 1 Kuhlenbaumer G, Young P, Hunermund G, Ringelstein B, Stogbauer F. Clinical features and molecular genetics of hereditary peripheral neuropathies.  J Neurol. 2002;  249 1629-1650
• 2 Charcot J M, Marie P. Sur une forme particuliere d’atrophie musculaire progressive, souvent familiale, debutant par les pieds et les jambs et atteignant plus tard les mains.  Rev Med. 1886;  6 97-138
• 3 Tooth H H. The Perone Type of Progressive Muscular Atrophy. London; HK Lewis and Co. 1886
• 4 Jaradeh S S. Hereditary neuropathies.  J Clin Neuromusc Dis. 2003;  5 72-80
• 5 Dejerine J, Sottas J. Sur la nevrite interstitielle, hypertrophique et progressive de l’enfance.  CR Soc Biol. 1893;  45 63-96
• 6 Roussy G, Levy G. A propos de la dystasia areflexique hereditaire.  Rev Neurol. 1934;  2 763-773
• 7 Dyck P J, Lambert E H. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy I. Neurologic, genetic and electrophysiologic findings in hereditary polyneuropathies.  Arch Neurol. 1968;  18 603-618
• 8 Dyck P J, Chance P, Lebo R et al.. Hereditary motor and sensory neuropathies. In: Dyck PJ, Thomas PK, Griffin JW, et al Peripheral Neuropathy. Vol. 2. 3rd ed. Philadelphia; WB Saunders 1993: 1094-1136
• 9 Harding A E, Thomas P K. The clinical features of hereditary motor and sensory neuropathy types I and II.  Brain. 1980;  103 259-280
• 10 Pareyson D. Diagnosis of hereditary neuropathies in adult patients.  J Neurol. 2003;  250 148-160
• 11 Pareyson D. Charcot-Marie-Tooth disease and related neuropathies: molecular basis for distinction and diagnosis.  Muscle Nerve. 1999;  22 1498-1509
• 12 Preston D, Shapiro B. Electromyography and Neuromuscular Disorders: Clinical-Electrophysiologic Correlations. Boston; Butterworth-Heinemann 1998
• 13 Berciano J, Combarros O, Calleja J et al.. The application of nerve conduction and clinical studies to genetic counseling in hereditary motor and sensory neuropathy type I.  Muscle Nerve. 1989;  12 302-306
• 14 Kaku D A, Parry G J, Malamut R et al.. Nerve conduction studies in Charcot-Marie-Tooth polyneuropathy associated with a segmental duplication of chromosome 17.  Neurology. 1993;  43 1806-1808
• 15 Nicholson G A. Penetrance of the hereditary motor and sensory neuropathy type 1A mutation: assessment by nerve conduction studies.  Neurology. 1991;  41 547-552
• 16 Hoogendijk J E, de Visser M, Bolhuis P A et al.. Hereditary motor and sensory neuropathy type 1: clinical and neurographical features of the 17p duplication subtype.  Muscle Nerve. 1994;  17 85-90
• 17 Killian J M, Tiwari P S, Jacobson S et al.. Longitudinal studies of the duplication form of Charcot-Marie-Tooth polyneuropathy.  Muscle Nerve. 1996;  19 74-78
• 18 Birouk N, Gouider R, Le Guern E et al.. Charcot-Marie-Tooth disease type 1A with 17p11.2 duplication. Clinical and electrophysiological phenotype study and factors influencing disease severity in 119 patients.  Brain. 1997;  120 813-823
• 19 Thomas P K, King R H, Small J R, Robertson A M. The pathology of Charcot-Marie-Tooth disease and related disorders.  Neuropathol Appl Neurobiol. 1996;  22 269-284
• 20 Lupski J, de Oca-Luna R M, Slaugenhaupt S et al.. DNA duplication associated with Charcot-Marie-Tooth disease type 1A.  Cell. 1991;  66 219-232
• 21 Nelis E, Van Broeckhoven C, De J P et al.. Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.  Eur J Hum Genet. 1996;  4 25-33
• 22 Raeymaikers P, Timmerman V, Nelis E et al.. Duplication in chromosome 17p11.2 in Charcot-Marie-Tooth neuropathy type 1a (CMT 1a). The HMSN Collaborative Research Group.  Neuromuscul Disord. 1991;  1 93-97
• 23 Matsunami N, Smith B, Ballard L et al.. Peripheral myelin protein-22 gene maps in the duplication in chromosome 17p11.2 associated with Charcot-Marie-Tooth 1A.  Nat Genet. 1992;  1 176-179
• 24 Timmerman V, Nelis E, Van Hul W et al.. The peripheral myelin protein gene PMP-22 is contained within the Charcot-Marie-Tooth disease type 1A duplication.  Nat Genet. 1992;  1 171-175
• 25 LeGuern E, Gouider R, Mabin D et al.. Patients homozygous for the 17p11.2 duplication in Charcot-Marie-Tooth type 1A disease.  Ann Neurol. 1997;  41 104-108
• 26 Hayasaka K, Takada G, Ionasescu V V. Mutation of the myelin P0 gene in Charcot-Marie-Tooth neuropathy type 1B.  Hum Mol Genet. 1993;  2 1369-1372
• 27 Tachi N, Kozuka N, Ohya K et al.. Tomaculous neuropathy in Charcot-Marie-Tooth disease with myelin protein zero gene mutation.  J Neurol Sci. 1997;  153 106-109
• 28 Plante-Bordeneuve V, Guiochon-Mantel A, Lacroix C et al.. The Roussy-Levy family: from the original description to the gene.  Ann Neurol. 1999;  46 770-773
• 29 Roa B B, Garcia C A, Suter U et al.. Charcot-Marie-Tooth disease type 1A. Association with a spontaneous point mutation in the PMP22 gene.  N Engl J Med. 1993;  329 96-101
• 30 Valentijn L, Baas F, Zorn I et al.. Alternatively sized duplication in Charcot-Marie-Tooth disease type 1A.  Hum Mol Genet. 1993;  2 2143-2146
• 31 Gabreels-Festen A A, Bolhuis P A, Hoogendijk J E et al.. Charcot-Marie-Tooth disease type 1A: morphological phenotype of the 17p duplication versus PMP22 point mutations.  Acta Neuropathol (Berl). 1995;  90 645-649
• 32 Manfioletti G, Ruaro M E, Del Sal G, Philipson L, Schneider C. A growth arrest-specific (gas) gene codes for a membrane protein.  Mol Cell Biol. 1990;  10 2924-2930
• 33 D’Urso D, Ehrhardt P, Muller H W. Peripheral myelin protein 22 and protein zero: a novel association in peripheral nervous system myelin.  J Neurosci. 1999;  19 3396-3403
• 34 Grohmann K, Schuelke M, Diers A et al.. Mutations in the gene encoding immunoglobulin mu-binding protein 2 cause spinal muscular atrophy with respiratory distress type 1.  Nat Genet. 2001;  29 75-77
• 35 Bird T, Ott J, Giblett E. Evidence for linkage of Charcot-Marie-Tooth neuropathy to the Duffy locus on chromosome 1.  Am J Hum Genet. 1982;  34 388-394
• 36 Gene Tests .Medical Genetics Information Resource (database online). Copyright, University of Washington and Children's Health System, Seattle, 1993-2004. Updated weekly. Available at: http://www.genetests.org Accessed April 23, 2004
• 37 Auer-Grumbach M, Strasser-Fuchs S, Wagner K, Korner E, Fazekas F. Roussy-Levy syndrome is a phenotypic variant of Charcot-Marie-Tooth syndrome IA associated with a duplication on chromosome 17p11.2  J Neurol Sci. 1998;  154 72-75
• 38 D'Urso D, Ehrhardt P, Muller H W. Protein zero of peripheral nerve myelin: biosynthesis, membrane insertion, and evidence for homotypic interaction.  Neuron. 1990;  4 449-460
• 39 Filbin M T, Walsh F S, Trapp B D, Pizzey J A, Tennekoon G I. Role of myelin P0 protein as a homophilic adhesion molecule.  Nature. 1990;  344 871-872
• 40 Ben Othmane K, Middleton L, Loprest L et al.. Localization of a gene (CMT2A) for autosomal dominant Charcot-Marie-Tooth disease type 2 to chromosome 1p and evidence of genetic heterogeneity.  Genomics. 1993;  17 370-375
• 41 Zhao C, Takita J, Tanaka Y et al.. Charcot-Marie-Tooth disease type 2A caused by mutation in a microtubule motor KIF1B beta.  Cell. 2001;  105 587-597
• 42 Vance J M, Speer M C, Stajich J M et al.. Misclassification and linkage of hereditary sensory and autonomic neuropathy type 1 as Charcot-Marie-Tooth disease, type 2B.  Am J Hum Genet. 1996;  59 258-262
• 43 Ionasescu V, Searby C, Sheffield V C et al.. Autosomal dominant Charcot-Marie-Tooth axonal neuropathy mapped on chromosome 7p (CMT2D).  Hum Mol Genet. 1996;  5 1373-1375
• 44 De Jonghe P, Mersivanova I, Nelis E et al.. Further evidence that neurofilament light chain gene mutations can cause Charcot-Marie-Tooth disease type 2E.  Ann Neurol. 2001;  49 245-249
• 45 Ismailov S M, Fedotov V P, Dadali E L et al.. A new locus for autosomal dominant Charcot-Marie-Tooth disease type 2 (CMT2F) maps to chromosome 7q11-q21.  Eur J Hum Genet. 2001;  9 646-650
• 46 Mersiyanova I V, Perepelov A V, Polyakov A V et al.. A new variant of Charcot-Marie-Tooth disease type 2 is probably the result of a mutation in the neurofilament-light gene.  Am J Hum Genet. 2000;  67 37-46
• 47 Chapon F, Latour P, Diraison P et al.. Axonal phenotype of Charcot-Marie-Tooth disease associated with a mutation in the myelin protein zero gene.  J Neurol Neurosurg Psychiatry. 1999;  66 779-782
• 48 Boerkoel C F, Takashima H, Stankiewicz P et al.. Periaxin mutations cause recessive Dejerine-Sottas neuropathy.  Am J Hum Genet. 2001;  68 325-333
• 49 Ionasescu V V, Kimura J, Searby C C et al.. A Dejerine-Sottas neuropathy family with a gene mapped on chromosome 8.  Muscle Nerve. 1996;  19 319-323
• 50 Ben Othmane K, Hentati F, Lennon F et al.. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q.  Hum Mol Genet. 1993;  2 1625-1628
• 51 Kalaydjieva L, Nikolova A, Turnev I et al.. Hereditary motor and sensory neuropathy-Lom, a novel demyelinating neuropathy associated with deafness in gypsies. Clinical, electrophysiological and nerve biopsy findings.  Brain. 1998;  121 399-408
• 52 Warner L E, Mancias P, Butler I J et al.. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies.  Nat Genet. 1998;  18 382-384
• 53 Delague V, Vareil C, Tuffery S et al.. Mapping of a new locus for autosomal recessive demyelinating Charcot-Marie-Tooth disease to 19q13.1-13.3 in a large consanguineous Lebanese family: exclusion of MAG as a candidate gene.  Am J Hum Genet. 2000;  67 236-243
• 54 Marques Jr W, Sweeney J G, Wood N W, Wroe S J, Marques W. Central nervous system involvement in a novel Connexin 32 mutation affecting identical twins.  J Neurol Neurosurg Psychiatry. 1999;  66 803-804
• 55 Bahr M, Andres F, Timmerman V et al.. Central visual, acoustic, and motor pathway involvement in a Charcot-Marie-Tooth family with an Asn2055Ser mutation in the Connexin 32 gene.  J Neurol Neurosurg Psychiatry. 1999;  66 202-206
• 56 Cowchock F S, Duckett S W, Streletz L J, Graziani L J, Jackson L G. X-linked motor-sensory neuropathy type-II with deafness and mental retardation: a new disorder.  Am J Med Genet. 1985;  20 307-315
• 57 Ionasescu V V, Trofatter J, Haines J L et al.. Heterogeneity in X-linked recessive Charcot-Marie-Tooth neuropathy.  Am J Hum Genet. 1991;  48 1075-1083
• 58 Bruzzone R, White T W, Paul D L. Connections with connexins: the molecular basis of direct intercellular signaling.  Eur J Biochem. 1996;  238 1-27
• 59 Dyck P J, Chance P, Lebo R, Carney J A. Neuronal atrophy and degeneration predominantly affecting peripheral sensory and autonomic neurons. In: Dyck PJ, Thomas PK Peripheral Neuropathy. Vol. 2. 3rd ed. Philadelphia; WB Saunders 1993: 1065-1093
• 60 Bejaoui K, Wu C, Scheffler M D et al.. SPTLC1 is mutated in hereditary sensory neuropathy, type 1.  Nat Genet. 2001;  27 261-262
• 61 Harding A E. Inherited neuronal atrophy and degeneration predominantly of lower motor neurons. In Dyck PJ, Thomas PK Peripheral Neuropathy. Vol. 2. 3rd ed. Philadelphia; WB Saunders 1993: 1051-1063
• 62 Latov N. Promising nerve regeneration drug tested by Neuropathy Association Researcher at Ohio State.  Neuropathy News. 2003;  17 1